Binding Determinants of Glycoprotein Hormone Receptors
糖蛋白激素受体的结合决定因素
基本信息
- 批准号:7171597
- 负责人:
- 金额:$ 33.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-01-01 至 2008-12-31
- 项目状态:已结题
- 来源:
- 关键词:Amino AcidsBindingBinding SitesBiochemicalC-terminalCCRCellsCharacteristicsCircular DichroismComplexCrystallizationCyclic AMPCysteineDataDevelopmentDrug DesignEpitopesEtiologyFemale infertilityFertilityFigs - dietaryFollicle Stimulating HormoneFollicle Stimulating Hormone ReceptorFractureG-Protein-Coupled ReceptorsGlycoproteinsHormone ReceptorHormonesHumanHyperthyroidismInvestigationKnowledgeLIM DomainLeucine-Rich RepeatLigand BindingLigandsLuteinizing HormoneManuscriptsMeasurementMetabolismMethodologyModelingMoldsMolecularMolecular ConformationMutagenesisMutationN-terminalNumbersOutcomePhysiologicalPrecocious PubertyPredispositionPreparationProcessPseudohermaphroditismReceptor ActivationReporterResearch PersonnelScanningSignal TransductionSiteSite-Directed MutagenesisStructureTestingThyrotropinTransmembrane DomainTreatment ProtocolsVariantbasecancer riskextracellulargain of functionmalignant breast neoplasmmolecular modelingmutantprogramsprotein expressionprotein purificationreceptorreceptor functionresearch studyresponsestoichiometrythree dimensional structure
项目摘要
DESCRIPTION (provided by applicant): The glycoprotein hormones (GpHs), luteinizing hormone (LH), follicle-stimulating hormone (FSH) and thyroid-stimulating hormone (TSH), regulate fertility and metabolism. Their receptors (GpHRs) are distinguished from most G protein-coupled receptors by the presence of large N-terminal extracellular hormone-binding domains (ECDs). Each ECD consists of nine leucine-rich repeats (LRRs), flanked by N-terminal and C-terminal cysteine-rich regions (NCR and CCR, respectively). The signal of specific hormone binding to the ECD is conveyed by its CCR to the heptahelical transmembrane region (TM). Mutations, activating or inactivating GpHR function, have been identified in hyperthyroidism, precocious puberty and pseudohermaphroditism; moreover, polymorphic variants of LH and FSH receptors have been shown to change the susceptibility to female infertility, breast cancer and risk of bone fractures. AIMS: 1. Identify common hormone-contact sites and key hormone-selective determinants in LRRs of GpHRs, 2. Identify residues in the cysteine-rich regions of GpHRs important for GpH binding and for conveying the binding signal to the TM, and 3. Determine the three-dimensional structure of GpH-GpHR complexes. METHODS: Domain exchange/site-directed mutagenesis, expression, hormone binding and cAMP-dependent reporter activity as readouts, molecular modeling, ECD protein expression, protein purification, crystallization, crystal structure determination. OUTCOME: The results of the proposed studies will increase our knowledge of the molecular mechanisms by which GpHRs recognize the 'correct' GpH, as well as the step-wise propagation of the signal to the TM following ligand binding. These data, in combination with the mutant 'gain-of-function' GpHRs, will be molded into a general model of GpHR activation, essential for the development of better treatment protocols and the rational design of drugs that change receptor activity. Moreover, these data may yield a better understanding of the etiology of different pathological states known for some GpH-GpHR pairs.
性状(由申请方提供):糖蛋白激素(GpHs)、促黄体生成素(LH)、促卵泡激素(FSH)和促甲状腺激素(TSH)调节生育力和代谢。它们的受体(GpHR)与大多数G蛋白偶联受体的区别在于存在大的N-末端胞外酶结合结构域(ECD)。每个ECD由9个富含亮氨酸的重复序列(LRR)组成,两侧分别是N-末端和C-末端富含半胱氨酸的区域(分别为NCR和CCR)。与ECD结合的特异性激素的信号通过其CCR传递到七螺旋跨膜区(TM)。突变,激活或失活GpHR功能,已被确定在甲状腺功能亢进症,性早熟和假两性畸形;此外,LH和FSH受体的多态性变体已被证明可以改变女性不孕症,乳腺癌和骨折的风险的易感性。目标:1.确定常见的酶接触位点和关键酶选择性决定因素的LRR的GpHRs,2。鉴定GpHR的富含半胱氨酸的区域中的残基,所述残基对于GpH结合和将结合信号传递至TM是重要的,以及3.确定GpH-GpHR复合物的三维结构。方法:结构域交换/定点诱变、表达、激素结合和cAMP依赖性报告活性作为读数、分子建模、ECD蛋白表达、蛋白纯化、结晶、晶体结构测定。结果:所提出的研究的结果将增加我们的知识的分子机制,GpHRs识别“正确的”GpH值,以及逐步传播的信号的TM配体结合。这些数据与突变的“功能获得性”GpHR结合,将被塑造成GpHR激活的一般模型,这对于开发更好的治疗方案和合理设计改变受体活性的药物至关重要。此外,这些数据可能会产生一个更好的理解的病因学不同的病理状态已知的一些GpH-GpHR对。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
J DAVID PUETT其他文献
J DAVID PUETT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('J DAVID PUETT', 18)}}的其他基金
Binding Determinants of Glycoprotein Hormone Receptors
糖蛋白激素受体的结合决定因素
- 批准号:
6855902 - 财政年份:2005
- 资助金额:
$ 33.6万 - 项目类别:
Binding Determinants of Glycoprotein Hormone Receptors
糖蛋白激素受体的结合决定因素
- 批准号:
7332216 - 财政年份:2005
- 资助金额:
$ 33.6万 - 项目类别:
Binding Determinants of Glycoprotein Hormone Receptors
糖蛋白激素受体的结合决定因素
- 批准号:
6995214 - 财政年份:2005
- 资助金额:
$ 33.6万 - 项目类别:
ENDORPHIN, PHENOTHIAZINE AND ENZYME SITES ON CALMODULIN
钙调蛋白上的内啡肽、吩噻嗪和酶位点
- 批准号:
3288115 - 财政年份:1985
- 资助金额:
$ 33.6万 - 项目类别:
ENDORPHIN, PHENOTHIAZINE AND ENZYME SITES ON CALMODULIN
钙调蛋白上的内啡肽、吩噻嗪和酶位点
- 批准号:
3288111 - 财政年份:1985
- 资助金额:
$ 33.6万 - 项目类别:
ENDORPHIN, PHENOTHIAZINE AND ENZYME SITES ON CALMODULIN
钙调蛋白上的内啡肽、吩噻嗪和酶位点
- 批准号:
3288116 - 财政年份:1985
- 资助金额:
$ 33.6万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
Bridging the Gap: Next-Gen Tools for Accurate Prediction of Disordered Protein Binding Sites
弥合差距:准确预测无序蛋白质结合位点的下一代工具
- 批准号:
24K15172 - 财政年份:2024
- 资助金额:
$ 33.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Design of protein crystal templates with multiple binding sites for tracking metal complex reactions.
设计具有多个结合位点的蛋白质晶体模板,用于跟踪金属络合物反应。
- 批准号:
23K04928 - 财政年份:2023
- 资助金额:
$ 33.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Dynamic changes in PIP2 binding sites and their impact on axonal targeting and function of epilepsy-associated KCNQ/Kv7 channels
PIP2 结合位点的动态变化及其对癫痫相关 KCNQ/Kv7 通道的轴突靶向和功能的影响
- 批准号:
10744934 - 财政年份:2023
- 资助金额:
$ 33.6万 - 项目类别:
Computational methods to identify small molecule RNA binding sites
识别小分子 RNA 结合位点的计算方法
- 批准号:
573688-2022 - 财政年份:2022
- 资助金额:
$ 33.6万 - 项目类别:
University Undergraduate Student Research Awards
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
- 批准号:
10704557 - 财政年份:2022
- 资助金额:
$ 33.6万 - 项目类别:
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
- 批准号:
10537846 - 财政年份:2022
- 资助金额:
$ 33.6万 - 项目类别:
Identifying new types of inhibitors in quinone binding sites in photosynthetic enzymes
鉴定光合酶醌结合位点的新型抑制剂
- 批准号:
2753921 - 财政年份:2022
- 资助金额:
$ 33.6万 - 项目类别:
Studentship
Development of broad nanovaccines targeting diverse coronavirus receptor-binding sites
开发针对不同冠状病毒受体结合位点的广泛纳米疫苗
- 批准号:
10328140 - 财政年份:2022
- 资助金额:
$ 33.6万 - 项目类别:
Exploiting Water Network Perturbations in Protein Binding Sites
利用蛋白质结合位点的水网络扰动
- 批准号:
10621368 - 财政年份:2021
- 资助金额:
$ 33.6万 - 项目类别:
SBIR Phase I: Nonlinear optical method for identifying protein-ligand binding sites
SBIR 第一阶段:识别蛋白质-配体结合位点的非线性光学方法
- 批准号:
2111821 - 财政年份:2021
- 资助金额:
$ 33.6万 - 项目类别:
Standard Grant